@nkrentz@UBC@ubcpharmacy Congrats Nicole! We are all lucky to have to you back and looking forward to seeing the exciting research produced by the Krentz lab!
⏰NOV 17 will be a big day for #T1D
"#Teplizumab represents a potentially disruptive new therapy for #T1D,..." Jason Hoitt @ProventionBio
The @US_FDA is expected to make a decision on the regulatory approval for #teplizumab on November 17, 2022 @JDRF
#WorldDiabetesDay2022
Thank you to those are brave to share your experiences of living with diabetes with the rest of us. Thank you to the souls and families who donate their islets to research. Thank you to the trainees who work their * off to gain more knowledge of diabetes!
Proud to be part of a remarkable diabetes research community and work at @BCCHresearch@BCChildrensHosp
I am fortunate to work with and learn from amazing colleagues, outstanding trainees in our lab, and persons with diabetes who are our partners and inspiration
#WorldDiabetesDay
@LumiraVentures @ubcentrepreneur Dr. Chris Tam of @IntegratedNTX presented a drug delivery platform that can deliver any type of drug modality in lipid nanoparticles, either alone or in combination, to disease cells and tissues for safer and more effective medicines that improve human health.
Thrilled to launch our @NSERC_CRSNG CREATE program in partnership with @JDRF_Canada, to provide funding, enhanced training, and research opportunities for graduate students and postdocs across Canada!
Program information and application details here:
https://t.co/ouuwIFGcLR
Interested in #EDI in #research in 🇨🇦? I’ve got good news for you! On Sept 1 (930am) @KirstyDuncanMP will share her views on the importance of EDI in research. If interested, Please click the link ⬇️
https://t.co/wb2WFWQSvY
@chumontreal@CRCHUM@UMontreal@med_umontreal
15 bookmark-worthy tools for researchers that cost you nothing and will save you time (& nerves) when researching, writing and publishing.
A thread. 🧵
#AcademicTwitter#AcademicChatter
Thread from my colleague @YCC_YiChunChen on her latest paper demonstrating proinsulin/C peptide as #biomarker for dysfunction of autologous islet transplants in mice and humans.
Delighted to share our work suggesting PI/C ratio as a predictive indicator of insulin dependency in autologous pancreatic islet transplant recipients🙂 (1/🧵)